Document Details
Form
Filing Date
Sep 5, 2024
Document Date
Sep 3, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Entrada Therapeutics
Issuer
Entrada Therapeutics, Inc.
Filer
DOWDEN NATHAN J